ANGEL-ASPECT Trial

Study of Endovascular Therapy in Acute Anterior Circulation Large VeSsel Occlusive Patients with a largE infarCT core (NCT 04551664)

[ANGEL-ASPECT Trial @angel_aspect]

Endovascular Therapy for Acute Stroke with a Large Ischemic Region | NEJM https://t.co/7hFhA1IYcY

[ANGEL-ASPECT Trial @angel_aspect]

ANGEL-ASPECT Trial update!
First interim analysis complete and the DSMB recommends continuing the study without modification!
Looking forward to thrombectomy evidence for large core (ASPECT 3-5) and infarct volume (70-100ml). @Fie0815 @TESLATrial @TENSIONstudy @VitorMendesPer1

[Xiaochuan Huo, MD 🇨🇳 @XiaochuanHuo]

https://t.co/2eWRJPBpbI

[AshuJadhav @AshuPJadhav]

Workflow Intervals and Outcomes of Endovascular Treatment for Acute Large-Vessel Occlusion During On-Vs. Off-hours in China: The ANGEL-ACT Registry https://t.co/4jbvaSZ6Fo

[JAMA Neurology @JAMANeuro]

Study found drug-eluting stent was effective to reduce the risk of in-stent restenosis and ischemic stroke recurrency in symptomatic high-grade intracranial atherosclerotic stenosis. https://t.co/6UhyUOMnid

[AshuJadhav @AshuPJadhav]

Selection criteria for large core trials: rationale for the ANGEL-ASPECT study design https://t.co/Rx7EFc1uqa

[JNIS @JNIS_BMJ]

JNIS Latest Content
Ren et al publish the rationale for the ANGEL-ASPECT trial of large core #stroke #thrombectomy in the setting of existing ongoing trials
@freealvin
https://t.co/StfNb7XX8c